The 2009-2014 World Outlook for Coronary Vasodilator Pharmaceuticals

Icon Group International, Inc.
September 27, 2008
186 Pages - SKU: ICON1972046
License type:
Countries covered: Global

This econometric study covers the world outlook for coronary vasodilator pharmaceuticals across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created.

This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world).

This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for coronary vasodilator pharmaceuticals. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.



Additional Information

This econometric study covers the world outlook for coronary vasodilator pharmaceuticals across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

More Global Cardiovascular Reports

Targeted Health and Wellness Foods and Beverages: The U.S. Market and Global Trends by Packaged Facts
The market for targeted health and wellness foods and beverages is a dynamic and promising one, driven largely by the growing recognition—among scientists, government, practitioners, ...

International Stroke Conference 2012 - Post-Conference Review and Analysis by GlobalData
International Stroke Conference 2012 - Post-Conference Review and Analysis Summary GlobalData, the industry analysis specialist, has released its new conference alerts, “International Stroke Conference 2012 - Post-Conference ...

Arrhythmias Global Clinical Trials Review, H1, 2012 by GlobalData
Arrhythmias Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Arrhythmias Global Clinical Trials Review, H1, 2012 provides data on the Arrhythmias clinical trial scenario. ...

Global ECG Telemetry Devices Market 2011-2014 by Infiniti Research Limited
TechNavio’s analysts forecast the Global ECG Telemetry Devices market to grow at a CAGR of 4.4 percent over the period 2010–2014. One of the key ...

Global Heart Valve Market Report: 2011 Edition by Koncept Analytics
The global heart valve market has recorded strong growth in the past years. During 2010, transcatheter aortic valve implant (TAVI) registered highest growth amongst all ...

See all reports like this >>